Defining a timeline with 🏔milestones, and scheduling 📝 in ⏰ for revisions and time for editor feedback is essential to stay on track 🏃🏼♀️
🔑 tip by @brentnreed don’t forget to schedule in time to encorporate editor feedback!
Tip#3️⃣ Determine a list of potential journals
Things to 🤔 about 📖 1. ✅ JANE criteria to see if similar 📓 was published recently? 2. Target 🎯 audience 3. Scope of the 📓 4. Impact factor @brentnreed suggests shooting one step higher than your intended journal 1/2
& do NOT be discouraged if you get rejected! 🙅
Shooting for the 🌟 with the journal (or one step higher than anticipated) can allow you to get high quality insightful feedback from the reviewers 👩🏻💻
Ensuring you encorporate that feedback and perseverance is 🔑
Tip#4️⃣ Develop a concept map 🗺 to help you structure your article 📝
Concept maps to assist w/ structure your 📝 & determine key concepts YOU want to bring out in the article and further help you define what has not been addressed in the current literature
Keeps you on 🎯 !
Tip#5️⃣ BE SURE TO ✅JOURNAL REQUIREMENTS PRIOR TO SUBMISSION!
Can be one of the most ⏰ consuming aspects of the review process if not previously reviewed.
👀 into ALL req (figures, tables, word count) for your article prior to submission to ease the writing & review process!
Tip #6️⃣ Clearly distinguish btwn methods results & discussion ☝️
➡️Methods can be written b4 the research is done! Just describes WHAT ur doing in the research, do not change this unless any major revisions were made during the study (ex. include or exclude pts based on ADR)1/2
Tip6️⃣ cont.
Results: just the facts & figures, do not analyze the data quite yet!
Discussion: here is where you can dive 🏄♀️ into discussing the 🔑 findings of your study in relation to current literature. Don’t forget to highlight strengths 👍 & limitations 👎🏻 of the study!
Tip #7️⃣ THIS ONE CHANGED OUR LIVES and will save you so much time and effort 😭 !
Use a reference manager 🖥 such as Zotero or Mendeley to ease the citation process!
We have all had those tough reviewers, and that’s ok we only learn from the feedback we receive! When it comes to a “challenging” reviewer- put on your thickest skin and be sure to politely & respectfully respond to all comments!
Just our final thought 💭 Have FUN!
Easier said than done but...Writing manuscripts IS DIFFICULT, but SO worth the effort!!
So each step🚶♀️along the way➡️give your self a pat on the back & reflect on what went well? what didn’t? Adjust accordingly!
Best of luck! 👏🏻
What additional tips do you have for residents to prepare a successful manuscript? 📝
Last week I had one of my final presentations of the year! With a catchy title😉
Urine for an Update! Updates in the management of metastatic urothelial cancer
Hold your bladders, this is an extensive update! 😂 #oncopharm
Bladder cancer can be divided into two ✌️subtypes: 1) Non-muscle invasive: encompasses in-situ and localized disease➡️5-yr OS >70%
2) Muscle invasive: encompasses regional or metastatic disease➡️5-yr OS dismal especially for metastatic disease 😔
Cisplatin=SOC
50% of pts w are ineligible due to older age👵🏻, poor PS, ⬇️ renal function, ⬇️hearing, neuropathy, heart failure 🫀& other comorbities that ⬆️ risk of ⚠️
Carboplatin yields inferior responses➡️NOT 🙅🏻♀️ an equal alternative due to ⬇️ OS😢➡️pt left w/minimal tx options
What medications 💊 are should be avoided 🛑 or used with caution ⚠️ in patients with Myasthenia Gravis? 🤔
See 👀 the thread 🧵below⤵️ that summarizes an amazing grand rounds presentation by @UKPharmRes PGY1 @AliW_PharmD on key 🔑 medication considerations in MG
1️⃣Antibiotics to avoid or use w/caution🦠 💊
🛑FQs = FDA BBW for ⤴️ risk of MG crisis ➡️ avoid use if possible
⚠️ Macrolides ⤴️ rate of MG crisis (case reports)
⚠️ AG linked to ⤴️ ICU acquired weakness & exacerbate ‼️ MG crisis
📝Risk⬆️ w/neomycin vs. tobramycin & amikacin
Antibiotics considered to be SAFE alternatives to the above include
✅Beta-lactams
✅Tetracyclines
✅Linezolid
✅Bactrim
Ex. In an MG patient who presents 🏥 w/CAP 🫁 ➡️ choose ceftriaxone + doxycycline✅ OVER ceftriaxone + azithromycin🛑